Crossing Boundaries in Drug Development: Perspectives on Drug Pricing and Reimbursement

This event, put on by the Healthcare Businesswomen’s Association Boston, will take a look at healthcare drug costs and reimbursements, as they relate to the pharmaceutical industry. Pfizer’s vice president of US payers and national accounts, Robyn Peters, will kick off the evening discussion. Register here by October 10. On-site registration is also available.